2. Deficit Hyperactivity Disorder: Diagnosis and Management Vitharon Boon-yasidhi M.D.* ABSTRACT Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder in childhood characterized by three clusters of symptoms: inattention, hyperactivity, and impulsivity. At least half of children with ADHD have impairing symptoms persisting to their adolescence or adulthood. The symptoms, particularly if not adequately treated, can have significant negative impacts on the patients’ school, family, and social functioning. Treatment of this condition should include a multi-modal approach, involving parent education, psychological interventions, educational intervention, and appropriate use of medications. This article provides a general overview and evidence based guidelines on the diagnosis and management of ADHD in children and adolescents. Keywords: Attention-deficit Hyperactivity Disorder (ADHD), guidelines J Psychiatr Assoc Thailand 2012; 57(4): 373-386 * Division of Child and Adolescent Psychiatry, Department of Pediatrics, Faculty of Medicine Siriraj Hospital 374 วารสารสมาคมจิตแพทย์แห่งประเทศไทย ปีท่ี 57 ฉบับที่ 4 ตุลาคม - ธันวาคม 2555
12. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996; 98:1089-95. 4. Brassett-Harknett A, Butler N. Attention-deficit/ hyperactivity disorder: an overview of the etiology and a review of the literature relating to the correlates and lifecourse outcomes for men and women. Clin Psychol Rev 2007; 27:188-210. 5. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164:942-8. 6. Wacharasindhu A, Panyyayong B. Psychiatric disorders in Thai school-aged children: I Prevalence. J Med Assoc Thai 2002; 85 Suppl 1:S125-36. 7. Schweitzer JB, Cummins TK, Kant CA. Attention-deficit/hyperactivity disorder. Med Clin North Am 2001; 85:757-77. 8. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:1313-23. 9. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attentiondeficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 2002; 41:378-85. 384 10. Mick E, Biederman J, Prince J, Fischer MJ, Faraone SV. Impact of low birth weight on attention-deficit hyperactivity disorder. J Dev Behav Pediatr 2002; 23:16-22. 11. Schonwald A. Update: attention deficit/ hyperactivity disorder in the primary care office. Curr Opin Pediatr 2005; 17:265-74. 12. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attentiondeficit/hyperactivity disorder. JAMA 2002; 288:1740-8. 13. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005; 57:1215-20. 14. Krain AL, Castellanos FX. Brain development and ADHD. Clin Psychol Rev 2006; 26:433-44. 15. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006; 45:192-202. 16. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002; 111:279-89. 17. Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000; 9:525-40. วารสารสมาคมจิตแพทย์แห่งประเทศไทย ปีท่ี 57 ฉบับที่ 4 ตุลาคม - ธันวาคม 2555
13. Disorder: Diagnosis and Management 18. Cantwell DP. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996; 35:978-87. 19. Leung AK, Lemay JF. Attention deficit hyperactivity disorder: an update. Adv Ther 2003; 20:305-18. 20. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:894-921. 21. American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108:1033-44. 22. Institute for Clinical Systems Improvement. Health Care Guideline: Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents. Available from: http://www.icsi.org/adhd/adhd_2300.html. [cited March 5, 2012]. 23. Boon-yasidhi, V. Diagnosis and management of attention-deficit/hyperactivity disorder. In: Krisanaprakornkrit T, Siungtrong P, Cholaprai C, eds. Srinagarind psychiatric update 2008. Khon Kaen: Anna Offset; 2008:65-74. 24. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56:1073-86. Vitharon Boon-yasidhi 25. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry 2004; 13 Suppl 1:I7-30. 26. Harpin VA. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006. Arch Dis Child Educ Pract Ed 2008; 93:58-65. 27. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002; 41:26S-49S. 28. McGough J, McCracken J, Swanson J, Riddle M, Kollins S, Greenhill L, et al. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006; 45:1314-22. 29. National Institute of Health. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement 1998; 16:1-37. 30. Kramer JR, Loney J, Ponto LB, Roberts MA, Grossman S. Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems. J Am Acad Child Adolesc Psychiatry 2000; 39:517-24. 31. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006; 45:642-57. J Psychiatr Assoc Thailand Vol. 57 No. 4 October - December 2012 385
14. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001; 24:99-102. 33. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111:179-85. 386 34. Gadow KD, Sverd J. Stimulants for ADHD in child patients with Tourette’s syndrome: the issue of relative risk. J Dev Behav Pediatr 1990; 11:269-71. 35. Barton J. Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. Arch Dis Child 2005; 90 Suppl 1:i26-9. 36. Lim JR, Faught PR, Chalasani NP, Molleston JP. Severe liver injury after initiating therapy with atomoxetine in two children. J Pediatr 2006; 148:831-4. วารสารสมาคมจิตแพทย์แห่งประเทศไทย ปีท่ี 57 ฉบับที่ 4 ตุลาคม - ธันวาคม 2555